EnvoyAI, Ambra Health, and TeraRecon Deliver First End-to-End AI Strategy


Leading AI, image sharing, and advanced viewing platforms simplify AI access and workflow


Las Vegas, NV (HIMSS18), March 06, 2018 (GLOBE NEWSWIRE) -- Las Vegas, NV - March 6th, 2018 -  TeraReconEnvoyAI, and Ambra Health, today announced a new collaboration to provide an AI-enhanced image exchange workflow. The partnership will enable healthcare providers to immediately implement an AI strategy through an Ambra image exchange workflow with access to the entire portfolio of AI algorithm solutions available on the EnvoyAI Exchange, leveraging their current PACS system or the full range of TeraRecon viewers. These AI workflows will be on display at the Healthcare Information & Management Systems Society (HIMSS18) annual meeting in Las Vegas, Nevada March 6th- 8th, 2018.

Andrew Duckworth, VP of Business Development of Ambra Health shared, "This interoperability partnership gives healthcare providers in the Ambra network access to bleeding edge AI technology for advanced image visualization, providing the very latest technological innovations to continually improve patient outcomes and care."

The EnvoyAI platform has continued to grow since the recent launch at RSNA17, with the partner count now standing at 20 contracted companies, contributing a total of 48 products, of which 10 have already achieved FDA-clearance.

TeraRecon's flagship product, iNtuition, provides advanced visualization capabilities, which now include embedded EnvoyAI image analysis engines within the typical advanced visualization workflow. iNtuition is already integrated with many leading PACS providers, so thousands of TeraRecon customers immediately have a way to implement a tightly integrated AI workflow that fits within their current PACS systems.

At HIMSS18, TeraRecon is also debuting the world's first AI results viewer, Northstar(TM). Newly-added features allow the latest version of the prototype viewer to interact with EnvoyAI results, providing the ability to accept, reject, and even adjust the EnvoyAI-derived findings.

Jeff Sorenson, CEO of TeraRecon stated: "Northstar is designed to be effortlessly embedded into all major PACS viewing platforms for an instant end-to-end AI strategy that spans from the selection of algorithms to the final end-user experience. Now, via the Ambra Health platform, our reach extends even further, to referring physicians needing access to AI and who require our industry-leading iNtuition advanced interpretation tools."

Jake Taylor, CTO of EnvoyAI, stated, "Through our partnerships with Ambra Health and TeraRecon, our technology can reach remote, single physician practices while also meeting the most demanding clinical needs of the largest integrated health systems."

To receive a demonstration of the integrated solution at HIMSS18, visit Ambra Health at booth #8324. EnvoyAI will be located at distribution partner, TeraRecon's, booth #3900. Online demonstrations are also available by contacting Ambra Health at or EnvoyAI at

About TeraRecon ( TeraRecon is a leader in advanced visualization, image viewing, and post-processing. Our flagship product, iNtuition, consistently leads the advanced visualization category of the industry's leading independent technology analyst. We are committed to redefining advanced visualization by leveraging artificial intelligence, and to improving radiology workflow through personalized automation features that increase efficiency.

About EnvoyAI ( EnvoyAI facilitates the streamlined distribution and hospital implementation of trained machine learning algorithms via a vendor neutral distribution platform. EnvoyAI provides a developer platform, integrations, and an open API for algorithm developers, technology partners, and end users. EnvoyAI assists research institutions and emerging AI companies in the translation and commercialization processes, starting with rapid deployment via a scalable, secure, cloud-based infrastructure with the ability to add local components to facilitate on-site deployments as well. EnvoyAI also works with distribution partners to make algorithms on the platform available to a very wide footprint of hospitals and, ultimately, to physicians.

About Ambra Health ( Ambra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. It empowers some of the largest health systems such as Memorial Hermann, Stanford Children's Health and New England Baptist Hospital as well as radiology practices, subspecialty practices and clinical research organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our extensive knowledge to deliver innovative medical image management solutions for the future of healthcare, now. Discover what the Ambra medical imaging cloud can do for you.

Press Inquiries US: 1-650-372-1100 |


A photo accompanying this announcement is available at

Lindsay Fleming

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: TeraRecon, Inc via Globenewswire




Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

3Gtms Positioned in the Niche Players Quadrant of the Gartner Magic Quadrant for Transportation Management Systems21.3.2018 15:00Pressmeddelande

Inclusion marks the first time 3Gtms has been named to the Magic Quadrant SHELTON, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- 3Gtms, Inc., a global provider of Tier 1 transportation management software, today announced it has been positioned by Gartner, Inc. in the Niche Players quadrant of the report, Magic Quadrant for Transportation Management Systems*. This is the first time 3Gtms has been positioned within the Magic Quadrant. According to the report, the research "focuses on holistic multimodal domestic TMSs for use by shippers (such as manufacturers, retailers, distributors and wholesalers) or non-asset-based, third-party logistics (3PL) organizations." Key criteria for the 2018 Magic Quadrant included: The breadth of the TMS; depth of the TMS; usability and adaptability; global go-to market strategy and offering; partner ecosystem; vision, thought leadership, roadmap, and track record; and a compelling SCE convergence strategy. The full report is available at no charge at the 3Gt

Further UHNWI Investment To Support FinTech Entrepreneur Zichain's Growth and Innovation21.3.2018 14:46Pressmeddelande

Zichain / Further UHNWI Investment To Support FinTech Entrepreneur Zichain's Growth and Innovation . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. ZURICH, Switzerland, March 21, 2018 (GLOBE NEWSWIRE) -- Zichain, a Switzerland-based digital asset management company, is pleased to announce that it has secured an USD 1.2m investment from a syndicate of UHNW Hong-Kong based investors, supporting further development of its unique cryptocurrency products. The deal was confirmed while the Company was participating at the Goldman Sachs 2018 Disruptive Technology Symposium, held in London on 20-21 March. As a pioneer of the cryptocurrency index industry, Zichain has enjoyed exponential growth with the Company now taking a leading role in the creation of digital asset management industry. Zichain is focused on the development of three key products: Blockchain Asset Management Platform (BAMP), a unique and convenien

Addivant Announces Price Increases on Hindered Amine Light Stablizers21.3.2018 14:38Pressmeddelande

DANBURY, Conn., March 21, 2018 (GLOBE NEWSWIRE) -- Effective immediately or as contract terms allow, Addivant(TM), a global leader in polymer additives, is increasing the price of Hindered Amine Light Stabilizers by up to 15%. The adjustment is driven by raw material cost increases and market conditions. About Addivant(TM) Addivant(TM) is an innovator in the field of polymer additives, developing customized solutions that provide customers enhanced application performance, safe handling, and reduction in cost of use. The company is recognized industry-wide for its extensive portfolio of specialty additives including antioxidants, light stabilizers, rubber additives, polymer modifiers, metal deactivators, polymerization inhibitors and intermediates. Addivant is an international company, with 11 plants in five regions as well as research, manufacturing and sales facilities around the globe. Addivant maintains its global headquarters in Connecticut, USA with regional headquarters in: Al J

VistaJet Connects Customers and Their Passions With the Global British Polo Day Tour21.3.2018 14:17Pressmeddelande

Customers to join the most prestigious worldwide polo tournament LONDON, March 21, 2018 (GLOBE NEWSWIRE) -- VistaJet, the first and only global private aviation company, will be offering customers the opportunity to enrich their passion for polo as the company partners with British Polo Day for the 2018 worldwide tournament, following a successful inaugurate partnership last year. The sport is a key interest for many of VistaJet's customers, both as spectators and riders, and is in line with 39% of the world's animal-loving Ultra High Net Worth population having a passion for horses*. VistaJet continuously develops and offers exceptional experiences for its customers inspired by their true passions, including art, sport and travel, across all cultures worldwide. Its global partnership with British Polo Day will offer customers an exclusive opportunity to enjoy one of their most cherished interests by watching some of the sport's top players, including the world's number one player Adol

Immunicum AB: Invitation to Investor Events21.3.2018 14:00Pressmeddelande

Press Release 21 March 2018 Immunicum AB: Invitation to Investor Events Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, announced today that the Company will host two investor events in April. At both events, Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session. Stockholm Date: Wednesday, April 11, 2018 Time: 18:00 - 20:00 CET Location: Citykonferensen Ingenjörshuset Room: Styrelserummet Malmskillnadsgatan 46 111 84 Stockholm Gothenburg Date: Wednesday, April 18, 2018 Time: 18:00 - 20:00 CET Location: First Hotel G Restaurant Orkidé Nils Ericsonplatsen 4 411 03 Gothenburg To register to attend the events, please send an email to with your full name and the selected location (Stockholm or Gothenburg). For more information, please contact:

Immunicum AB: Inbjudan till investerarkvällar21.3.2018 14:00Pressmeddelande

Pressmeddelande 21 mars 2018 Immunicum AB: Inbjudan till investerarkvällar Immunicum AB (IMMU.ST), ett bioteknikbolag som utvecklar nya immunostimulerande cancerbehandlingar för ett antal solida tumörformer, meddelade idag att bolaget kommer att ordna två investerarkvällar i april. Vid båda tillfällena kommer Immunicums VD Carlos de Sousa att hålla en presentation av det dagsaktuella läget i bolaget, och han och övriga medlemmar i ledningen är tillgängliga för att svara på frågor. Stockholm Datum: onsdag, 11 april 2018 Tid: 18:00-20:00 CET Plats: Citykonferensen Ingenjörshuset Sal: Styrelserummet Malmskillnadsgatan 46 111 84 Stockholm Göteborg Datum: onsdag, 18 april 2018 Tid: 18:00-20:00 CET Plats: First Hotel G Sal: Orkidé i restaurangen Nils Ericsonplatsen 4 411 03 Göteborg För att delta i investerarkvällarna, skicka ett mejl till med ditt fullständiga namn och orten där du vill delta (Stockholm eller Göteborg). För ytterligare information kontakta: Carlos de So

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum